These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

919 related items for PubMed ID: 20577082

  • 21. The effect of heart rate on wave reflections may be determined by the level of aortic stiffness: clinical and technical implications.
    Papaioannou TG, Vlachopoulos CV, Alexopoulos NA, Dima I, Pietri PG, Protogerou AD, Vyssoulis GG, Stefanadis CI.
    Am J Hypertens; 2008 Mar; 21(3):334-40. PubMed ID: 18219305
    [Abstract] [Full Text] [Related]

  • 22. Effects of nebivolol or irbesartan in combination with hydrochlorothiazide on vascular functions in newly-diagnosed hypertensive patients: the NINFE (Nebivololo, Irbesartan Nella Funzione Endoteliale) study.
    Vitale C, Marazzi G, Iellamo F, Spoletini I, Dall'Armi V, Fini M, Volterrani M.
    Int J Cardiol; 2012 Mar 08; 155(2):279-84. PubMed ID: 22078979
    [Abstract] [Full Text] [Related]

  • 23. From 'optimal' to 'borderline' blood pressure in subjects under chronic antihypertensive therapy.
    Vergnaud AC, Protogerou AD, Blacher J, Safar ME.
    J Hypertens; 2008 Jan 08; 26(1):138-44. PubMed ID: 18090551
    [Abstract] [Full Text] [Related]

  • 24. Differential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patients.
    Matsui Y, Eguchi K, O'Rourke MF, Ishikawa J, Miyashita H, Shimada K, Kario K.
    Hypertension; 2009 Oct 08; 54(4):716-23. PubMed ID: 19667251
    [Abstract] [Full Text] [Related]

  • 25. Acute effects of third generation β-blockers on short-term and beat-to-beat blood pressure variability in sinoaortic-denervated rats.
    Bertera FM, Del Mauro JS, Lovera V, Chiappetta D, Polizio AH, Taira CA, Höcht C.
    Hypertens Res; 2013 Apr 08; 36(4):349-55. PubMed ID: 23364340
    [Abstract] [Full Text] [Related]

  • 26. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW, Laugerotte A, Wright JM.
    Cochrane Database Syst Rev; 2015 Aug 26; 2015(8):CD007449. PubMed ID: 26306578
    [Abstract] [Full Text] [Related]

  • 27. Do losartan and atenolol have differential effects on BNP and central haemodynamic parameters?
    Davies J, Carr E, Band M, Morris A, Struthers A.
    J Renin Angiotensin Aldosterone Syst; 2005 Dec 26; 6(3):151-3. PubMed ID: 16525946
    [Abstract] [Full Text] [Related]

  • 28. Beta-blocking therapy in patients with the Marfan syndrome and entire aortic replacement.
    Meijboom LJ, Westerhof BE, Nollen GJ, Spaan JA, de Mol BA, Jacobs MJ, Mulder BJ.
    Eur J Cardiothorac Surg; 2004 Nov 26; 26(5):901-6. PubMed ID: 15519180
    [Abstract] [Full Text] [Related]

  • 29. Effects of carvedilol as third-line add-on therapy on blood pressure and glucose metabolism in type 2 diabetic patients with chronic renal disease stage 3 and above.
    Yasuda G, Yatsu K, Yamamoto Y, Hirawa N.
    Kidney Blood Press Res; 2012 Nov 26; 36(1):131-8. PubMed ID: 23095799
    [Abstract] [Full Text] [Related]

  • 30. Effect of lisinopril and atenolol on aortic stiffness in patients on hemodialysis.
    Georgianos PI, Agarwal R.
    Clin J Am Soc Nephrol; 2015 Apr 07; 10(4):639-45. PubMed ID: 25784174
    [Abstract] [Full Text] [Related]

  • 31. Effects of atenolol, perindopril and verapamil on haemodynamic and vascular function in Marfan syndrome - a randomised, double-blind, crossover trial.
    Williams A, Kenny D, Wilson D, Fagenello G, Nelson M, Dunstan F, Cockcroft J, Stuart G, Fraser AG.
    Eur J Clin Invest; 2012 Aug 07; 42(8):891-9. PubMed ID: 22471392
    [Abstract] [Full Text] [Related]

  • 32. Arterial stiffness, central blood pressures, and wave reflections in cardiomyopathy-implications for risk stratification.
    Weber T, Auer J, Lamm G, O'Rourke MF, Eber B.
    J Card Fail; 2007 Jun 07; 13(5):353-9. PubMed ID: 17602981
    [Abstract] [Full Text] [Related]

  • 33. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, Umemura S.
    Hypertens Res; 2006 Mar 07; 29(3):143-51. PubMed ID: 16755149
    [Abstract] [Full Text] [Related]

  • 34. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms.
    Nichols WW.
    Am J Hypertens; 2005 Jan 07; 18(1 Pt 2):3S-10S. PubMed ID: 15683725
    [Abstract] [Full Text] [Related]

  • 35. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM, Chamontin B, Asmar R, De Leeuw PW, O'Brien E, Duprez D, O'Rourke MF, Rahn KH, Romero R, Battegay E, Hitzenberger G, Safar ME, REASON Project.
    Am J Hypertens; 2004 Mar 07; 17(3):245-51. PubMed ID: 15001199
    [Abstract] [Full Text] [Related]

  • 36. Effects of antihypertensive drugs on central blood pressure in humans: a preliminary observation.
    Agnoletti D, Zhang Y, Borghi C, Blacher J, Safar ME.
    Am J Hypertens; 2013 Aug 07; 26(8):1045-52. PubMed ID: 23736112
    [Abstract] [Full Text] [Related]

  • 37. Mechanical vs intrinsic components in the improvement of brachial arterial compliance. Comparison of the effects of atenolol versus ramipril in hypertensive patients.
    Armentano RL, Graf S, Ramírez AJ, Espinosa JD, Brandani L, Baglivo H, Sánchez R.
    Medicina (B Aires); 2001 Aug 07; 61(5 Pt 1):535-40. PubMed ID: 11721319
    [Abstract] [Full Text] [Related]

  • 38. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials.
    Shahin Y, Khan JA, Chetter I.
    Atherosclerosis; 2012 Mar 07; 221(1):18-33. PubMed ID: 22209214
    [Abstract] [Full Text] [Related]

  • 39. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlöf B, Scherstén B.
    Blood Press; 2004 Mar 07; 13(3):137-41. PubMed ID: 15223721
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and tolerability of nebivolol: does age matter? A retrospective analysis of three randomized, placebo-controlled trials in stage I-II hypertension.
    Germino FW, Lin Y, Pejović V, Bowen L.
    Ther Adv Cardiovasc Dis; 2012 Oct 07; 6(5):185-99. PubMed ID: 23008339
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.